Frame-based stereotactic biopsies of brainstem lesions - Monocentric comparison of the transfrontal and the suboccipital-transcerebellar approach over a 16-year period.


Journal

Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181

Informations de publication

Date de publication:
01 Nov 2024
Historique:
received: 28 07 2024
accepted: 27 10 2024
revised: 16 09 2024
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 1 11 2024
Statut: epublish

Résumé

Both the transfrontal and the suboccipital-transcerebellar approach are frequently used trajectories for frame-based stereotactic biopsies of brainstem lesions. Nevertheless, it remains unclear which approach is more favorable in terms of complications, diagnostic success and outcome, especially considering the location of the lesion within the brainstem. This study compared the safety and diagnostic yield of these two approaches. Furthermore, a brainstem zone model was created to answer the question, whether there is a favorable approach depending on the location of the lesion in the brainstem. A retrospective analysis of 84 consecutive cases of frame-based stereotactic biopsies for brainstem lesions via either transfrontal or suboccipital-transcerebellar approaches over a 16-year period was performed. Clinical and surgical data regarding trajectories, histopathology, complications and outcome was collected. The brainstem was divided in anatomical zones to compare the use of the two approaches depending on the location of the lesions. A total of n = 84 cases of stereotactic biopsies for brainstem lesions were performed. In 36 cases the suboccipital-transcerebellar approach was used, while in 48 cases surgery was performed via the transfrontal approach. The patient's demographic data were comparable between the two approaches. Overall diagnostic yield was 90.5% (93.8% transfrontal vs. 86.1% suboccipital, p = 0.21, Risk Difference (RD) 0.077, CI [-0.0550, 0.2090]). Complications occurred in 11 cases (total complication rate: 13.1%; 12.5% transfrontal vs. 13.9% suboccipital, p = 0.55, RD 0.014, CI [-0.1607, 0.1327]). The brainstem model showed a more frequent use of the suboccipital approach in lesions of the dorsal pons. The transfrontal approach was used more frequently in mesencephalic targets. No significant differences in terms of complications and diagnostic yield were observed, even though complications in medullary lesions appeared higher using the transfrontal approach. This study showed, that if the approaches are used for their intended target locations there are no significant differences between the transfrontal and the suboccipital-transcerebellar approach for frame-based stereotactic biopsies of brainstem lesions in terms of diagnostic yield and safety. Therefore, our data suggests that both approaches should be considered for stereotactic biopsy of brainstem lesions.

Identifiants

pubmed: 39482553
doi: 10.1007/s10143-024-03075-8
pii: 10.1007/s10143-024-03075-8
doi:

Types de publication

Journal Article Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

832

Informations de copyright

© 2024. The Author(s).

Références

Bahrami E, Parvaresh M, Bahrami M, Fattahi A (2020) An Experience with Frame-Based Stereotactic Biopsy of Posterior Fossa Lesions via Transcerebellar Route. World Neurosurg 136:e380–e385. https://doi.org/10.1016/j.wneu.2020.01.003
doi: 10.1016/j.wneu.2020.01.003 pubmed: 31931238
Beynon C, Hoffmann T, Wick W, Unterberg A, Kiening K (2011) Stereotactic brainstem biopsy in a patient with coagulopathy of unclear etiology: case report. Min - Minim Invasive Neurosurg 54:268–270. https://doi.org/10.1055/s-0031-1297989
doi: 10.1055/s-0031-1297989 pubmed: 22278794
Beynon C, Neumann J-O, Bösel J, Unterberg AW, Kiening KL (2013) Stereotactic biopsy and drainage of a brainstem abscess caused by listeria monocytogenes: —case report—. Neurol Med Chir (Tokyo) 53:263–265. https://doi.org/10.2176/nmc.53.263
doi: 10.2176/nmc.53.263 pubmed: 23615421
Beynon C, Wei S, Radbruch A, Capper D, Unterberg AW, Kiening KL (2018) Preoperative assessment of haemostasis in patients undergoing stereotactic brain biopsy. J Clin Neurosci 53:112–116. https://doi.org/10.1016/j.jocn.2018.04.035
doi: 10.1016/j.jocn.2018.04.035 pubmed: 29685415
Chen S-Y, Chen C-H, Sun M-H, Lee H-T, Shen C-C (2011) Stereotactic biopsy for brainstem lesion: Comparison of approaches and reports of 10 cases. J Chin Med Assoc 74:110–114. https://doi.org/10.1016/j.jcma.2011.01.024
doi: 10.1016/j.jcma.2011.01.024 pubmed: 21421204
Cheng G, Yu X, Zhao H, Cao W, Li H, Li Q, Li Z, Yin F, Liu R, Zhang J (2020) Complications of stereotactic biopsy of lesions in the sellar region, pineal gland, and brainstem: A retrospective, single-center study. Medicine (Baltimore) 99:e18572. https://doi.org/10.1097/MD.0000000000018572
doi: 10.1097/MD.0000000000018572 pubmed: 32080071
Dellaretti M, Reyns N, Touzet G, Dubois F, Gusmão S, Pereira JLB, Blond S (2012) Stereotactic biopsy for brainstem tumors: comparison of transcerebellar with transfrontal approach. Stereotact Funct Neurosurg 90:79–83. https://doi.org/10.1159/000335502
doi: 10.1159/000335502 pubmed: 22286495
Escobar-Vidarte OA, Griswold DP, Orozco-Mera J, Mier-Garcia JF, Peralta Pizza F (2022) A case series of stereotactic biopsy of brainstem lesions through the transfrontal approach. J Neurol Surg Rep 83:e123–e128. https://doi.org/10.1055/s-0042-1758696
doi: 10.1055/s-0042-1758696 pubmed: 36467870 pmcid: 9708407
Furtak J, Śledzińska P, Bebyn MG, Szylberg T, Krajewski S, Birski M, Harat M (2021) Infratentorial stereotactic biopsy of brainstem and cerebellar lesions. Brain Sci 11:1432. https://doi.org/10.3390/brainsci11111432
doi: 10.3390/brainsci11111432 pubmed: 34827431 pmcid: 8615913
Hamisch C, Kickingereder P, Fischer M, Simon T, Ruge MI (2017) Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases. J Neurosurg Pediatr 20:261–268. https://doi.org/10.3171/2017.2.PEDS1665
doi: 10.3171/2017.2.PEDS1665 pubmed: 28621573
He L, He D, Qi Y, Zhou J, Yuan C, Chang H, Wang Q, Li G, Shao Q (2021) Stereotactic biopsy for brainstem lesions: a meta-analysis with noncomparative binary data. Cancer Control 28:107327482110598. https://doi.org/10.1177/10732748211059858
doi: 10.1177/10732748211059858
Hirano Y, Shinya Y, Aono T, Hasegawa H, Kawashima M, Shin M, Takami H, Takayanagi S, Umekawa M, Ikemura M, Ushiku T, Taoka K, Tanaka S, Saito N (2022) The role of stereotactic frame-based biopsy for brainstem tumors in the era of molecular-based diagnosis and treatment decisions. Curr Oncol 29:4558–4565. https://doi.org/10.3390/curroncol29070360
doi: 10.3390/curroncol29070360 pubmed: 35877220 pmcid: 9318548
Jaradat A, Nowacki A, Fichtner J, Schlaeppi J-A, Pollo C (2021) Stereotactic biopsies of brainstem lesions: which approach? Acta Neurochir (Wien) 163:1957–1964. https://doi.org/10.1007/s00701-021-04733-2
doi: 10.1007/s00701-021-04733-2 pubmed: 33538882
Jung I, Chang KW, Park SH, Moon JH, Kim EH, Jung HH, Kang S, Chang JH, Chang JW, Chang WS (2021) Stereotactic biopsy for adult brainstem lesions: A surgical approach and its diagnostic value according to the 2016 World Health Organization Classification. Cancer Med 10:7514–7524. https://doi.org/10.1002/cam4.4272
doi: 10.1002/cam4.4272 pubmed: 34510820 pmcid: 8559459
Machetanz K, Grimm F, Wang S, Schuhmann MU, Tatagiba M, Gharabaghi A, Naros G (2022) Rediscovery of the transcerebellar approach: improving the risk-benefit ratio in robot-assisted brainstem biopsies. Neurosurg Focus 52:E12. https://doi.org/10.3171/2021.10.FOCUS21359
doi: 10.3171/2021.10.FOCUS21359 pubmed: 34973665
Malaizé H, Laigle-Donadey F, Riche M, Marijon P, Mokhtari K, Bielle F, Tran S, Nichelli L, Beccaria K, Idbaih A, Hoang-Xuan K, Touat M, Carpentier A, Mathon B, the PSL BRAIN-BIOPSY STUDY GROUP (2022) Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesion. J Neurooncol 160:159–170. https://doi.org/10.1007/s11060-022-04129-x
doi: 10.1007/s11060-022-04129-x pubmed: 36083426
Nakagawa JM, Trippel M, Doostkam S, Mader I, Coenen VA, Reinacher PC (2018) The stereotactic suboccipitaltranscerebellar approach to lesions of the brainstem and the cerebellum. Clin Neurol Neurosurg 166:10–15. https://doi.org/10.1016/j.clineuro.2018.01.015
doi: 10.1016/j.clineuro.2018.01.015 pubmed: 29358106
Navarro-Olvera JL, Aguado-Carrillo G, Vintimilla-Sarmiento JD, Parra-Romero G, Guartazaca-Guerrero MS, Carrillo-Ruiz JD (2022) Concordancia y rendimiento diagnóstico de biopsias estereotáxicas para fosa posterior: técnica y experiencia en un hospital de referencia. Cir Cir 90:6417. https://doi.org/10.24875/CIRU.21000237
doi: 10.24875/CIRU.21000237
Neumann J-O, Campos B, Younes B, Jakobs M, Jungk C, Beynon C, von Deimling A, Unterberg A, Kiening K (2018) Frame-based stereotactic biopsies using an intraoperative MR-scanner are as safe and effective as conventional stereotactic procedures. PLoS ONE 13:e0205772. https://doi.org/10.1371/journal.pone.0205772
doi: 10.1371/journal.pone.0205772 pubmed: 30352066 pmcid: 6198960
Patel P, Balamurugan M (2009) Transcerebellar stereotactic biopsy for brainstem lesions in children. J Pediatr Neurosci 4:17. https://doi.org/10.4103/1817-1745.49101
doi: 10.4103/1817-1745.49101 pubmed: 21887169 pmcid: 3162830
Peciu-Florianu I, Legrand V, Monfilliette-Djelad A, Maurage C-A, Vannod-Michel Q, Blond S, Touzet G, Reyns N (2022) Frameless robot-assisted stereotactic biopsies for lesions of the brainstem—a series of 103 consecutive biopsies. J Neurooncol 157:109–119. https://doi.org/10.1007/s11060-022-03952-6
doi: 10.1007/s11060-022-03952-6 pubmed: 35083580
Phi JH, Chung H-T, Wang K-C, Ryu SK, Kim S-K (2013) Transcerebellar biopsy of diffuse pontine gliomas in children: a technical note. Childs Nerv Syst 29:489–493. https://doi.org/10.1007/s00381-012-1933-3
doi: 10.1007/s00381-012-1933-3 pubmed: 23053360
Quick-Weller J, Lescher S, Bruder M, Dinc N, Behmanesh B, Seifert V, Weise L, Marquardt G (2016) Stereotactic biopsy of brainstem lesions: 21 years experiences of a single center. J Neurooncol 129:243–250. https://doi.org/10.1007/s11060-016-2166-1
doi: 10.1007/s11060-016-2166-1 pubmed: 27291894
Rachinger W, Grau S, Holtmannspotter M, Herms J, Tonn J-C, Kreth FW (2009) Serial stereotactic biopsy of brainstem lesions in adults improves diagnostic accuracy compared with MRI only. J Neurol Neurosurg Psychiatry 80:1134–1139. https://doi.org/10.1136/jnnp.2009.174250
doi: 10.1136/jnnp.2009.174250 pubmed: 19520698
Riche M, Amelot A, Peyre M, Capelle L, Carpentier A, Mathon B (2021) Complications after frame-based stereotactic brain biopsy: a systematic review. Neurosurg Rev 44:301–307. https://doi.org/10.1007/s10143-019-01234-w
doi: 10.1007/s10143-019-01234-w pubmed: 31900737
Riche M, Marijon P, Amelot A, Bielle F, Mokhtari K, Chambrun MPD, Joncour AL, Idbaih A, Touat M, Do C-H, Deme M, Pasqualotto R, Jacquens A, Degos V, Shotar E, Chougar L, Carpentier A, Mathon B (2022) Severity, timeline, and management of complications after stereotactic brain biopsy. J Neurosurg 136:867–876. https://doi.org/10.3171/2021.3.JNS21134
doi: 10.3171/2021.3.JNS21134 pubmed: 34507289
Simonelli M, Dipasquale A, Orzan F, Lorenzi E, Persico P, Navarria P, Pessina F, Nibali MC, Bello L, Santoro A, Boccaccio C (2020) Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients’ management: Close to the clinic? Crit Rev Oncol Hematol 146:102879. https://doi.org/10.1016/j.critrevonc.2020.102879
doi: 10.1016/j.critrevonc.2020.102879 pubmed: 32005411
Starup-Hansen J, Williams SC, Funnell JP, Hanrahan JG, Islam S, Al-Mohammad A, Hill CS (2023) Optimising trajectory planning for stereotactic brain tumour biopsy using artificial intelligence: a systematic review of the literature. Br J Neurosurg 1–10. https://doi.org/10.1080/02688697.2023.2210225

Auteurs

Manuel Kaes (M)

Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. Manuel.kaes@med.uni-heidelberg.de.
Division for Stereotactic Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. Manuel.kaes@med.uni-heidelberg.de.
Medical Faculty, Heidelberg University, Grabengasse 1, 69117, Heidelberg, Germany. Manuel.kaes@med.uni-heidelberg.de.

Jan-Oliver Neumann (JO)

Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Division for Stereotactic Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Medical Faculty, Heidelberg University, Grabengasse 1, 69117, Heidelberg, Germany.

Christopher Beynon (C)

Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Medical Faculty, Heidelberg University, Grabengasse 1, 69117, Heidelberg, Germany.

Paul V Naser (PV)

Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Division for Stereotactic Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Medical Faculty, Heidelberg University, Grabengasse 1, 69117, Heidelberg, Germany.

Karl Kiening (K)

Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Division for Stereotactic Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Medical Faculty, Heidelberg University, Grabengasse 1, 69117, Heidelberg, Germany.

Sandro M Krieg (SM)

Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Medical Faculty, Heidelberg University, Grabengasse 1, 69117, Heidelberg, Germany.

Martin Jakobs (M)

Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Division for Stereotactic Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Medical Faculty, Heidelberg University, Grabengasse 1, 69117, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH